摘要 |
The present invention relates to use of (thio)-carbamoyl-cyclohexane derivatives, particularly trans-4- {2-[4-(2,3 -dichlorophenyl)-piperazin-1-yl] -ethyl} -N,N- dimethylcarbamoyl-cyclohexylamine and pharmaceutically acceptable salts thereof in the manufacture of a medicament for the treatment of schizophrenia. Furthermore, the present invention relates to the treatment of schizophrenia through the administration of (thio)- carbamoyl cyclohexane derivatives, particularly trans-4- {2-[4-(2,3-dichlorophenyl)-piperazin- 1-yl] -ethyl}-N,N-dimethylcarbamoyl-cyclohexylamine and pharmaceutically acceptable salts thereof. |